Morley D Hollenberg
Overview
Explore the profile of Morley D Hollenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
219
Citations
5247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kollath V, Venu V, Saifeddine M, Mihara K, Hirota S, Hollenberg M, et al.
Nanoscale Adv
. 2024 Dec;
7(3):830-839.
PMID: 39691557
Biocompatible polymeric nanoparticles (NPs) as carriers for therapeutic agents with multifunctional activities have received unprecedented attention for a variety of bio-pharmaceutical applications. We describe the synthesis, the fluorescence properties, the...
2.
Sarkar A, Fanous K, Marei I, Ding H, Ladjimi M, MacDonald R, et al.
Vasc Health Risk Manag
. 2024 Jun;
20:255-288.
PMID: 38919471
Metformin is an orally effective anti-hyperglycemic drug that despite being introduced over 60 years ago is still utilized by an estimated 120 to 150 million people worldwide for the treatment...
3.
Guignard S, Saifeddine M, Mihara K, Motahhary M, Savignac M, Guiraud L, et al.
Br J Pharmacol
. 2024 Apr;
181(16):2725-2749.
PMID: 38637276
Background And Purpose: Chymotrypsin is a pancreatic protease secreted into the lumen of the small intestine to digest food proteins. We hypothesized that chymotrypsin activity may be found close to...
4.
Morin C, Baeva M, Hollenberg M, Brain M
Mult Scler Relat Disord
. 2024 Feb;
83:105477.
PMID: 38308914
Despite having been formally defined over 150 years ago, the etiology of multiple sclerosis (MS) is still relatively unknown. However, it is now recognized as a multifactorial disease in which...
5.
Lahiri P, Arrazuria R, Tan Y, De Buck J, Hollenberg M, Orsel K, et al.
Infect Immun
. 2024 Jan;
92(2):e0034223.
PMID: 38189287
Digital dermatitis (DD) is a skin disease in cattle characterized by painful inflammatory ulcerative lesions in the feet, mostly associated with local colonization by spp., including . The reason why...
6.
Alexander S, Christopoulos A, Davenport A, Kelly E, Mathie A, Peters J, et al.
Br J Pharmacol
. 2023 Dec;
180 Suppl 2:S23-S144.
PMID: 38123151
The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of...
7.
Eftekhari R, Ewanchuk B, Rawji K, Yates R, Noorbakhsh F, Kuipers H, et al.
J Pharmacol Exp Ther
. 2023 Sep;
388(1):12-22.
PMID: 37699708
Proteinase-activated receptor-2 (PAR2), which modulates inflammatory responses, is elevated in the central nervous system in multiple sclerosis (MS) and in its murine model, experimental autoimmune encephalomyelitis (EAE). In PAR2-null mice,...
8.
Yan B, Gui Y, Guo Y, Sun J, Saifeddine M, Deng J, et al.
Cells
. 2023 Jun;
12(11).
PMID: 37296583
(+)-JQ1, a specific chemical inhibitor of bromodomain and extraterminal (BET) family protein 4 (BRD4), has been reported to inhibit smooth muscle cell (SMC) proliferation and mouse neointima formation via BRD4...
9.
Soh W, Zhang J, Hollenberg M, Vliagoftis H, Rothenberg M, Sokol C, et al.
Allergy
. 2023 Feb;
78(5):1148-1168.
PMID: 36794967
Tremendous progress in the last few years has been made to explain how seemingly harmless environmental proteins from different origins can induce potent Th2-biased inflammatory responses. Convergent findings have shown...
10.
Zhang X, Lee M, Buckley C, Hollenberg M, Wilson C, McCarron J
J Cell Physiol
. 2023 Feb;
238(4):776-789.
PMID: 36791026
Protease-activated receptor-1 & -2 (PAR1 and PAR2) are expressed widely in cardiovascular tissues including endothelial and smooth muscle cells. PAR1 and PAR2 may regulate blood pressure via changes in vascular...